Dr. Yuhchyau Chen, MD

Dr. Chen practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Chen's NPI, 1730119603, was assigned on July 4, 2006. Dr. Chen graduated from University Of Washington School Of Medicine in 1990. Dr. Chen holds New York license 199614.

Dr. Chen's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Chen's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. Chen is also affiliated with Highland Hospital. The medical group on file is Noyes Health. Dmand AI also links Dr. Chen to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Chen is licensed in New York.

CMS data shows 256 Medicare services from Dr. Chen across 5 procedure codes in 2024, for 76 Medicare patients. Medicare paid $14,208 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 76 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 34 patients. 72% of them have high cholesterol, and 71% have cancer. 17% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 72, with 46% women.

In 2024, Dr. Chen wrote 24 Medicare Part D claims for 15 patients. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $385 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 116 papers to Dr. Chen, published from 2006 to 2025. 2017 was the busiest year, with 12. The most frequent topics are Lung Neoplasms, Prostatic Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Chen has published most often in Int J Radiat Oncol Biol Phys. Dr. Chen's most frequent co-authors are Jeff Michael Michalski, MD, Michael T. Milano, MD and Amit Bhalchadra Shah, MD.

Dmand AI links Dr. Chen to 10 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung and Adenocarcinoma Of Esophagus. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 24 general payments to Dr. Chen from 5 drug and device companies from 2017 to 2024. Travel and lodging make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,950.

Dr. Chen graduated from University Of Washington School Of Medicine in 1990.